Biggest News Aggregation in the World
๐Ÿ“ฐ Prostate News

Page 107 - Prostate News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Prostate. Real-time updates on events, politics, business and more.

"Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed" by Mathieu Gaudreault, David Chang et al.

Background: Biology-guided radiotherapy (BgRT) uses real-time functional imaging to guide radiation therapy treatment. Positron emission tomography (PET) tracers targeting prostate-specific membrane antigen (PSMA) are superior for prostate cancer detection than conventional imaging. This study aims at describing nodal and distant metastasis distribution from prostate cancer and at determining the proportion of metastatic lesions suitable for BgRT. Methods: A single-institution patient subset fro...
Source: uow.edu.au

"HDR prostate brachytherapy plan robustness and its effect on in-vivo s" by Joel Poder, Dylan Koprivec et al.

Purpose: The purpose of this study was to examine the effect of departmental planning techniques on appropriate in-vivo source tracking error thresholds for high dose rate (HDR) prostate brachytherapy (BT) treatments, and to determine if a single in-vivo source tracking error threshold would be appropriate for the same patient anatomy. Methods: The prostate, rectum, and urethra were contoured on a single patient transrectal ultrasound (TRUS) dataset. Anonymized DICOM files were disseminated to 1...
N Vivo Source Tracking
Source: uow.edu.au

Discovery of new prostate cancer subtype opens the door to development of therapies

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.
Ekta Khurana Emily Henderson Worldquant Foundation Research Scholar Edward Meyer Cancer Center Epigenetics Program Memorial Sloan Kettering Cancer Center

Combined treatment approach proves to be beneficial for prostate cancer patients

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy-;a commonly used hormone injection-;plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.
Dan Theodorescu Howard Sandler Emily Henderson Laboratory Medicine Department Of Radiation Oncology At Cedars Cedars Sinai Cancer

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or cardiovascular issues than patients who were only receiving hormone therapy, Michigan Medicine researchers found.
United States Lilliany Lai Emily Henderson Urologic Oncology Research Fellow At Michigan Medicine National Institutes Of Health Michigan Medicine

New technology may pave the way for development of point-of-care devices and diagnostic tests

Biomarkers are components that may be present in biological samples and are related to specific diseases. Therefore, doctors can analyze biological samples from a patient to check their health condition or to monitor the progress of a specific therapy.
South Korea Yoon Kyoung Cho Emily Henderson Institute For Basic Science Professor Cho Living Matter

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science